CY1114282T1 - Pyrimidine derivatives used as inhibitors of PI-3 kinase - Google Patents

Pyrimidine derivatives used as inhibitors of PI-3 kinase

Info

Publication number
CY1114282T1
CY1114282T1 CY20131100742T CY131100742T CY1114282T1 CY 1114282 T1 CY1114282 T1 CY 1114282T1 CY 20131100742 T CY20131100742 T CY 20131100742T CY 131100742 T CY131100742 T CY 131100742T CY 1114282 T1 CY1114282 T1 CY 1114282T1
Authority
CY
Cyprus
Prior art keywords
kinase
inhibitors
pyrimidine derivatives
derivatives used
pharmaceutically acceptable
Prior art date
Application number
CY20131100742T
Other languages
Greek (el)
Inventor
Matthew Burger
Zhi-Jie Ni
Sabina Pecchi
Gordana Atallah
Sarah Bartulis
Kelly Frazier
Aaron Smith
Joelle Verhagen
Yanchen Zhang
Allan Wagman
Simon Ng
Keith Pfister
Daniel Poon
Alicia Louie
Teresa Pick
Paul Barsanti
Edwin Iwanowicz
Wendy Fantl
Thomas Hendrickson
Mark Knapp
Hanne Meritt
Charles Voliva
Marion Wiesmann
Xiahua Xin
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10173136.2A external-priority patent/EP2261223B1/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CY1114282T1 publication Critical patent/CY1114282T1/en

Links

Abstract

Ενώσεις (Ι) που αναστέλλουν την 3-κινάση της φωσφατιδυλοϊνοσιτόλης (ΡΙ), τα φαρμακευτικώς αποδεκτά άλατα τους σε συνδυασμό με τουλάχιστον ένα επιπλέον θεραπευτικό παράγοντα, με έναν φαρμακευτικώς αποδεκτό φορέα, για την πρόληψη ή την θεραπεία νεοπλασματικών νοσημάτων που χαρακτηρίζονται από την ανώμαλη δραστηριότητα των αυξητικών παραγόντων, των κινασών σερίνης/ θρεονίνης, και κινασών των φωσφολιπιδίων.Compounds (I) that inhibit phosphatidylinositol 3-kinase (PI), their pharmaceutically acceptable salts in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier, for the prevention or treatment of neoplastic diseases characterized by growth factors, serine / threonine kinases, and phospholipid kinases.

CY20131100742T 2006-01-20 2013-08-28 Pyrimidine derivatives used as inhibitors of PI-3 kinase CY1114282T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76078906A 2006-01-20 2006-01-20
EP10173136.2A EP2261223B1 (en) 2006-01-20 2007-01-22 Pyrimidine derivatives used as pi-3 kinase inhibitors

Publications (1)

Publication Number Publication Date
CY1114282T1 true CY1114282T1 (en) 2016-08-31

Family

ID=58436435

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100742T CY1114282T1 (en) 2006-01-20 2013-08-28 Pyrimidine derivatives used as inhibitors of PI-3 kinase

Country Status (1)

Country Link
CY (1) CY1114282T1 (en)

Similar Documents

Publication Publication Date Title
CY1111091T1 (en) Pyrimidine derivatives used as PI-3 kinase inhibitors
MX2010000716A (en) Bicyclic heteroaryl compounds and their use as kinase inhibitors.
MX2008010397A (en) Pi-3 kinase inhibitors and methods of their use.
CY1121338T1 (en) USE OF SALTS OF KINASE INHIBITOR JANUS (R) -3- (4- (7H-PYROROLO [2,3-D] PYRIMIDIN-4-YLO) -1H-PYRAZOL-1-YLO) -3-CYCLOPENTYLONT-
CY1117995T1 (en) SECONDARY PRODUCTS OF CATEGOLAMIN AND MEDICINES CONTAINING THE THESE COMPOUNDS
NI201000004A (en) TRISUSTITUED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES.
DOP2009000159A (en) POLY INHIBITORS (ADP-RIBOSA) POLYMERASE
GEP20125691B (en) Compounds and compositions as protein kinase inhibitors
DE602006007037D1 (en) Pyrrolotriazine KINASE INHIBITORS
SG132683A1 (en) Imidazopyrazine tyrosine kinase inhibitors
EA201170249A1 (en) 3,4-DIARILPYRAZOLE AS A PROTEINKINAZ INHIBITOR
GT200900283A (en) "COMBINATION THERAPY WITH A COMPOUND ACTING AS AN ADP PLAQUETARY RECEPTOR INHIBITOR".
CU23831B1 (en) PIRROLO-PYRIMIDINE COMPOUNDS
SV2010003776A (en) PIRIMIDINE DERIVATIVES AS CINASE INHIBITORS
CO6270257A2 (en) DERIVATIVES OF PIRIDAZINONA
NI201000003A (en) TRISUSTITUED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES.
AR063097A1 (en) PIRAZOLOPIRIMIDINAS [1,5-A] INHIBITORS OF CYCLINE-DEPENDENT KINASES (CDK), PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES IN THE TREATMENT OF PROLIFERATIVE DISEASES
CY1112478T1 (en) KINAZOLINONE COMPOUNDS AS ANTI-CANCER FACTORS
EA200801945A1 (en) PYRROLOTRIAZINANILINUM MEDICAL AND MEDICINAL COMPOUNDS, USEFUL AS KINASE INHIBITORS
DK2316831T3 (en) 2- (Morpholin-4-yl) pyrimidines as phosphotidylinositol (PI) -3-kinase inhibitors and their use in the treatment of cancer
NZ517758A (en) Pyrazolopyrimidines useful as therapeutic agents
MX2009011950A (en) Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors.
HK1133012A1 (en) Pyrimidinones as casein kinase ii (ck2) modulators
UY30298A1 (en) C-FMS II QUINASE INHIBITORS
DK1981851T3 (en) KINASE INHIBITORS AND PROCEDURES FOR USE THEREOF